Back
Monte Rosa Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
11
GLUE
Monte Rosa Therapeutics
Last Price:
$7.05
Seasonality Move:
-4.72%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight selling pressure.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.07 | Sell |
| 20-day SMA: | 8.28 | Sell |
| 50-day SMA: | 8.1 | Sell |
| 200-day SMA: | 5.94 | Buy |
| 8-day EMA: | 7.25 | Sell |
| 20-day EMA: | 7.78 | Sell |
| 50-day EMA: | 7.73 | Sell |
| 200-day EMA: | 6.4 | Buy |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 41.56 | Sell |
| Chaikin Money Flow: | -108020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.21 - 9.49) | Sell |
| Bollinger Bands (100): | (5.02 - 8.56) | Buy |
Monte Rosa Therapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 7.06 while GLUE 8-day simple moving average is 7.07, which is a Sell signal.
-
The stock price of GLUE is 7.06 while Monte Rosa Therapeutics 20-day SMA is 8.28, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day simple moving average is 8.10 while GLUE share price is 7.06, making it a Sell technically.
-
GLUE stock price is 7.06 and Monte Rosa Therapeutics 200-day simple moving average is 5.94, creating a Buy signal.
GLUE Technical Analysis vs Fundamental Analysis
Sell
11
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a SellThe current Monte Rosa Therapeutics [GLUE] share price is $7.06. The Score for GLUE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
433.7M
Price in USD:
7.06
Share Volume:
828.2K
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
3.21
Sell
11
Monte Rosa Therapeutics (GLUE)
is a Sell
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?The Monte Rosa Therapeutics stock price is 7.06 USD today.
-
Will GLUE stock go up or go down?Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monte Rosa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 7.06 while GLUE 8-day exponential moving average is 7.25, which is a Sell signal.
-
The stock price of GLUE is 7.06 while Monte Rosa Therapeutics 20-day EMA is 7.78, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day exponential moving average is 7.73 while GLUE share price is 7.06, making it a Sell technically.
-
GLUE stock price is 7.06 and Monte Rosa Therapeutics 200-day simple moving average is 6.40, creating a Buy signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.28 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
-
GLUE Moving Average Covergence Divergence (MACD) indicator is -0.41, suggesting Monte Rosa Therapeutics is a Sell
-
Monte Rosa Therapeutics Relative Strength Index (RSI) is 41.56, which suggest Monte Rosa Therapeutics is oversold
-
The Bollinger Bands (25) for Monte Rosa Therapeutics is (7.21 - 9.49), which suggest Monte Rosa Therapeutics is a Buy
-
The Bollinger Bands (100) for Monte Rosa Therapeutics is (5.02 - 8.56), which suggest Monte Rosa Therapeutics is a Buy
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.